Lobbying

Dialysis Patient Citizens's latest lobbying report covers Q2 2026, at $530K. The four quarters Q4 2025–Q3 2026 total $1.1M. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

Dialysis Patient Citizens

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$1.1M
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Dialysis Patient Citizens lobbying by quarter
Dialysis Patient Citizens lobbying by quarter
QuarterAmountReports
Q4 2022$510K3
Q1 2023$260K3
Q2 2023$310K3
Q3 2023$310K3
Q4 2023$460K3
Q1 2024$360K3
Q2 2024$560K3
Q3 2024$530K3
Q4 2024$280K3
Q1 2025$280K2
Q2 2025$430K2
Q3 2025$430K2
Q4 2025$280K2
Q1 2026$280K2
Q2 2026$530K2
Q3 2026$00

By issue

  • Medicare and Medicaid$5.3M · 22 reports
  • Health issues$555K · 22 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES36 reports
  • SENATE34 reports
  • Centers For Medicare and Medicaid Services (CMS)18 reports
  • Health & Human Services, Dept of (HHS)16 reports
  • White House Office15 reports
  • Labor, Dept of (DOL)13 reports
  • Health Resources & Services Administration (HRSA)2 reports

Firms it paid

Firm
In-houseDialysis Patient Citizens$5.2M15 quarters
Kountoupes Denham Carr & Reid$450K15 quarters
Prime Policy Group$210K8 quarters
The Petrizzo Group$01 quarters

Former officials lobbying for it

Former position
LESLIE ZELENKODeputy Assistant Secretary for Legislation, Senior Advisor/Congressional Liaison-HHS; Legislative Director,Senior Legislative Assistant,Legislative Assistant,Legislative Correspondent-Cong. Mark Pocan, D-WI; Staff Assistant-Cong. Tammy Baldwin, D-WIQ1 2024
RICH MEADE1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of RepresentativesQ2 2023

Lobbying reports

Filed by
07/20for Q2In-house$500K
07/09for Q2Kountoupes Denham Carr & Reid$30K
04/19for Q1In-house$250K
04/09for Q1Kountoupes Denham Carr & Reid$30K
01/20for Q4 2025In-house$250K
01/15for Q4 2025Kountoupes Denham Carr & Reid$30K
25/10/21for Q3 2025In-house$400K
25/10/14for Q3 2025Kountoupes Denham Carr & Reid$30K
25/07/31for Q2 2025In-house$400K
25/07/16for Q2 2025Kountoupes Denham Carr & Reid$30K
25/04/21for Q1 2025In-house$250K
25/04/14for Q1 2025Kountoupes Denham Carr & Reid$30K
25/01/17for Q4 2024In-house$250K
25/01/15for Q4 2024Kountoupes Denham Carr & Reid$30K
24/11/09for Q4 2024The Petrizzo GroupUnder $5,000
24/10/21for Q3 2024In-house$500K
24/10/16for Q3 2024Kountoupes Denham Carr & Reid$30K
24/10/14for Q3 2024Prime Policy GroupUnder $5,000
24/10/02for Q4 2024The Petrizzo GroupUnder $5,000
24/07/19for Q2 2024In-house$500K